Health In Tech, Inc.

Health In Tech maintains a conservative capital structure with zero debt-to-equity and a current ratio of 3.13, supported by $10.3 million in cash and equivalents against $7.4 million in total liabilities. The company holds $21.6 million in total equity, providing a strong liquidity buffer despite negative operating cash flow of $3.3 million in Q1 2026. The absence of debt eliminates interest coverage risk, while the high current ratio indicates ample short-term asset coverage for liabilities.

Profitability remains negative with a net loss of $1.6 million in Q1 2026, resulting in a negative return on equity of -0.0592 and return on assets of -0.0441. The company trades at a price-to-book multiple of 2.48 and an EV-to-revenue multiple of 1.3, reflecting market skepticism toward current earnings generation. Gross profit of $4.5 million on $8.8 million in revenue indicates a gross margin of approximately 51%, suggesting underlying operational efficiency before operating expenses and stock-based compensation drag on net income.

Health In Tech, Inc. (HIT) has recorded its first notable institutional holder activity, marking a significant baseline event for the company. As of March 31, 2026, investor ID 471 added a position of 183,325 shares, valued at approximately $0.27 million. This acquisition represents a weight of roughly 0.0017% of the company’s total equity, signaling initial institutional interest in the ticker. This development is particularly material because it constitutes the first analysis for this ticker, meaning there is no prior basis for computing delta changes in holder behavior. The addition of this holder provides the first concrete data point regarding institutional ownership structure, establishing a reference point for future monitoring of capital flows into Health In Tech, Inc. The significance of this entry is underscored by the company’s current profile, which includes zero analyst coverage and no index memberships. With only six top holders identified to date, the addition of investor ID 471 contributes to a still-emerging shareholder base. The lack of analyst presence suggests that price discovery and valuation metrics remain driven primarily by direct investor activity rather than consensus estimates. For market observers, this holder change serves as the primary signal of external validation for Health In Tech, Inc. at this stage. While the absolute value of the position is modest, the act of entry by a tracked investor indicates a level of due diligence and potential confidence in the company’s trajectory. Future changes in this holder’s position or the addition of new institutional players will be critical indicators of growing market interest. [doc:hit-companyfacts] [doc:hit-10-k-2026-03-25]

Revenue $8.8M; Net margin -18.1%.

• ▍Revenue $8.8M
• ▍Net margin -18.1%

Revenue $25.8M; Net margin 6.1%.

• ▍Revenue $25.8M
• ▍Net margin 6.1%

Revenue $17.3M; Net margin 6.5%.

• ▍Revenue $17.3M
• ▍Net margin 6.5%

Revenue $33.3M; Net margin 3.8%.

• ▍Revenue $33.3M
• ▍Net margin 3.8%

Revenue $19.5M.

• ▍Revenue $19.5M

Revenue $19.5M; Net margin 3.4%.

• ▍Revenue $19.5M
• ▍Net margin 3.4%

Revenue $19.2M.

• ▍Revenue $19.2M